Located in New York City, BioHemp International is an early stage venture firm focused on establishing a portfolio of product brands, and distribution channels, for the growing cannabidiol (CBD) market. The Company’s management team holds years of experience in private equity, startup development, and financial consulting, which they plan to utilize in developing out future growth through strategic rollups and acquisitions. www.biohempinternational.com
With the passage of the 2018 Farm Bill, which formally legalized hemp crop and its extracts, primarily CBD, the consumer market in the US is poised for exponential growth. The Brightfield Group, a research agency specializing in Hemp and CBD market research, projects that the CBD market is expected to reach an estimated value of $22 billion by 2022. Bio-Hemp International is looking to capitalize and leverage the public markets to grab market share through consolidation to become the market leader in the exploding CBD sector.
By creating a PLATFORM that will have combine equity and capital to facilitate acquisitions of premium branded PRODUCT which will be managed by a team with extensive industry expertise within both product development, and private equity. This is the formula that BioHemp International will equate towards success in establishing itself as the CBD market leader.